Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trans sodium crocetinate for treatment of COVID-19
IRCT20081019001369N7Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of trans sodium crocetinate in coronavirus disease 2019 (COVID-19), sponsored by Mashhad University of Medical Sciences. Started Oct 2020; status: completed.
02
Drugs
trans sodium crocetinate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20081019001369N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20081019001369N7.